Intuitive Surgical Announces Strong Q1 2025 Earnings

Worldwide da Vinci procedures grew approximately 17% compared to Q1 2024.

The company placed 367 da Vinci surgical systems, including 147 da Vinci 5 systems.

Revenue increased by 19% to $2.25 billion, driven by procedure volume and system placements.

GAAP net income attributable to Intuitive Surgical was $698 million, or $1.92 per diluted share.

The company expects worldwide da Vinci procedure growth of approximately 15% to 17% in 2025.

da Vinci Procedure Growth:: The increase in da Vinci procedures is a key driver of revenue growth, indicating strong demand for robotic-assisted surgery.

da Vinci 5 Adoption:: The rapid adoption of the da Vinci 5 system, with 147 placements in Q1 2025, demonstrates the market's acceptance of the new technology.

Geographic Expansion:: Growth in the Asia-Pacific region, particularly in China, Japan, and India, contributed to increased system placements and procedure volume.

Tariff Risks:: The company's non-GAAP gross profit margin outlook includes an estimated impact from tariffs of 1.7% of revenue. Potential increases in tariffs could materially impact financial results.

Competition:: Emerging domestic robotic systems, particularly in China, may pose a competitive challenge.

Q: What was the revenue growth in Q1 2025?

Q: How many da Vinci 5 systems were placed in Q1 2025?

Q: What is the expected da Vinci procedure growth for 2025?

Intuitive Surgical's Q1 2025 results reflect strong growth in da Vinci procedures and system placements.

The company's revenue increased by 19% to $2.25 billion, driven by increased adoption of its robotic-assisted surgery platforms.

The rapid adoption of the da Vinci 5 system demonstrates the market's acceptance of the new technology.

Investors should monitor tariff risks and potential competitive challenges from emerging domestic robotic systems.